Intro

This chapter delves into immune-related adverse events (irAEs) linked to immunotherapy, particularly immune checkpoint inhibitors. The hosts discuss the mechanisms of immunotherapy, including tumor mutational burden and the role of immune checkpoints in cancer treatment.